Overall, our study revealed that the prevalence of post-diagnosis SI was 26.3% among Chinese hospitalized cancer patients. Patients with symptoms of insomnia or lack of appetite were at higher likelihood of reporting SI, even after adjusting for socio-demographic variables (marital status, being retired), clinical variables (stage at diagnosis, metastasis) and diagnosed depression. Furthermore, our findings suggest a marginally exaggerating effect of low health self-efficacy on pain and SI, after adjusted for all the confounding variables.
In the current study, 26.3% of the hospitalized patients reported SI following cancer diagnosis, which was higher than the previous reports (15.3-18.4%) in Chinese cancer population [25, 40, 41]. and it was also higher than that in some Western studies (7.8-17.7%)[14, 17-20], but much lower than that in Japan and Korea (34.7-71%)[23, 42-44].Our data was comparable to those of previous researches in Spain, the United States and Taiwan (22.6-29.5)[4, 13, 15]. The prevalence of SI varies from different studies based on different sample and measures. The majority of the sample were cancer patients of the digestive system and lung cancer, and those diagnosed with stage III and IV accounted for 70% of the total sample. Previous studies indicated cancer site and stage at diagnosis were associated factors for SI[14, 44]. Moreover, the scale utilized in our study included passive and active SI as the outcome, the passive SI referred to the death ideation as a wish to die or would be better off dead, the active SI refers to thoughts of killing oneself[45], which can elevated the prevalence.
To our best knowledge, this is the first study to examine the associations of physical symptoms, health self-efficacy and SI, and their interactions on SI among cancer patients. In line with our hypothesis, we found that patients with specific physical symptoms were more likely to report SI. Lack of appetite was about two times associated with the odds of SI after adjusted for socio-demographic and clinical characteristics. Choi et al. found physical symptoms were significantly associated with SI in stomach cancer population[23]. Prior studies demonstrated that patients with difficulties in vital function, such as eating, experience more helplessness/hopelessness and were therefore at higher risk of SI[24, 44]. The observed relationship between insomnia and SI is biologically plausible. Sleeping loss can cause various endocrine and immunological changes, prior studies have proved that dysfunction of the serotonin (5-hydroxytriptamine) plays a significant role in suicide[46]. Besides, insufficient sleep may negatively impact cognitive function resulting in poor judgment, deficits in impulse control, which might contribute to SI and behaviors.[47]. Moreover, insomnia as a diagnostic criterion of depression and also strongly associated with co-occurring mental disorders[48], which in turn are associated with increased risk for suicidality.
In consistent with our second hypothesis, our study suggested that low health self-efficacy played a marginally significant exaggerating effect on the association between pain and SI. Studies have found that patients with comparable levels of pain tend to have less depressive symptoms if they have higher health self-efficacy[49]. Health self-efficacy reflects individual’s perceived ability to cope with stress and confidence in overcoming challenges to their health[29, 30]. Prior evidence showed that cancer patients perceived higher health self-efficacy reported lower psychological distress levels and higher quality of life[31]. In contrast, as a result of low self-efficacy, individuals may prematurely terminate their coping efforts and instead consider how to escape the distressing situation and think of suicide.
There are some limitations in our study. First, our sample were recruited in cancer departments from two general hospitals in northeast China, thus the results may limit generalization to the cancer-specialized hospitals or the outpatients settings. Second, respondents may have not reported SI due to stigma or embarrassment related to suicide behaviors, the prevalence of SI reported in our study might be an underestimation. Third, patients who refused or did not complete this interview may experience severe physical adverse effects or emotional distress, which may product a selection bias, and we did not compare the demographic differences between participants who completed the survey and those who did not. Fourth, the physical symptoms assessed in the past two days, which might include occasional symptoms and might not occur simultaneously with SI seems to be a serious limitation of this study. Fifth, the variable of depressive symptoms was based on HRSD-17 scores, we may lose some information by using a cutoff score to dichotomize the variable of diagnosed depression instead of using continuous HRSD-17 scores. In addition, for the HRSD scale contains items on SI, insomnia and weight loss, we repeated adjusted the confounder of depressive symptoms severity based on HRSD-17 total scores and HRSD-12 scores without SI, sleep and weight items (see Additional 2-Appendix table3-4). Sixth, apart from depression disorders, we did not identify other mental disorders in analyzing the predictors. Finally, owing to the cross-sectional study, no direct causal relationship can be made. longitudinal research is needed on health self-efficacy interventions in reducing suicidal thoughts and further risks of suicide, such as future intent or prior suicide attempts.
One in four cancer patients undergoing treatment reported SI after diagnosis, indicates that the high-risk on suicidality remains an issue for this population in China. There are several clinical implications. First, to prevent suicide in cancer patients, we suggest that clinicians pay attention to patients’ physical symptoms, especially insomnia and lack of appetite, which may lead to SI directly. Second, Provide cognitive behavioral therapy and skills to manage physical symptoms for the patients may yield meaningful results. Third, improvement in the sense of health self-efficacy in those with low health self-efficacy patients are essential for hospital suicide prevention, especially in cancer patients with pain. We believe we can identify physical indicators and provide long-term screening and psychological treatment to ameliorate the risk of suicide in cancer patients.